These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17327638)
1. [Specific features of neovascularization of dysplastic invasiveness and cancer of the breast]. Khadyrov EA; Mchedlishvili MIu Georgian Med News; 2007 Jan; (142):60-3. PubMed ID: 17327638 [TBL] [Abstract][Full Text] [Related]
2. [Morphogenetic potential of the communication systems in breast dysplasia and fibroadenoma]. Abrosimov SIu; Dorosevich AE; Golubev OA Arkh Patol; 1996; 58(3):33-7. PubMed ID: 8967840 [TBL] [Abstract][Full Text] [Related]
3. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer. Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082 [TBL] [Abstract][Full Text] [Related]
4. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer. Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575 [TBL] [Abstract][Full Text] [Related]
5. The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis. Jung I; Gurzu S; Raica M; Cîmpean AM; Szentirmay Z Rom J Morphol Embryol; 2009; 50(2):239-43. PubMed ID: 19434317 [TBL] [Abstract][Full Text] [Related]
6. Benign breast disease and the risk of breast cancer in the next 15 years. Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956 [TBL] [Abstract][Full Text] [Related]
7. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
8. Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions. Midulla C; Pisani T; De Iorio P; Cenci M; Divizia E; Nofroni I; Vecchione A Anticancer Res; 2002; 22(2B):1341-5. PubMed ID: 12168948 [TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma--an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy. Chan MS; Wang L; Chanplakorn N; Tamaki K; Ueno T; Toi M; Loo WT; Chow LW; Suzuki T; Sasano H Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S69-78. PubMed ID: 22309693 [TBL] [Abstract][Full Text] [Related]
10. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach. Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974 [TBL] [Abstract][Full Text] [Related]
11. [Ki 67 growth fraction in carcinomas and benign lesions of the breast]. Kunz J; Schmidt A Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121 [TBL] [Abstract][Full Text] [Related]
12. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403 [TBL] [Abstract][Full Text] [Related]
13. Cystic fibroadenoma: report of a rare case with review of literature. Bhat A; Vijaya C; Gowda VS Breast Dis; 2015; 35(1):49-52. PubMed ID: 25095984 [TBL] [Abstract][Full Text] [Related]
14. [Immunomorphological research on human breast tumors using monoclonal antibodies to intermediate filament proteins. The proliferative epithelial structures in fibrocystic disease (dysplasia) and benign tumors]. Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Litvinova LV; Bannikov GA Arkh Patol; 1986; 48(8):7-14. PubMed ID: 3778238 [TBL] [Abstract][Full Text] [Related]